The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial safety assessment of MAGE-A10c796TCR T-cells in two clinical trials.
 
Vincent K. Lam
No Relationships to Disclose
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; Oncorena
Honoraria - Adaptimmune; Baxter; Bayer; Merrimack
Consulting or Advisory Role - Baxter; Bayer; Guidepoint Global; Janssen
Research Funding - Abbvie; Adaptimmune; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech; Genmab; Ignyta; Infinity Pharmaceuticals; Kite, a Gilead company; Kyowa Hakko Kirin; Lilly; Loxo; MedImmune; Merck; Mirati Therapeutics; miRNA Therapeutics; Molecular Templates; Novartis; Pfizer; Takeda
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
Other Relationship - Oncorena
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Merck
Research Funding - Abbvie (Inst); Adaptimmune (Inst); AstraZeneca (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); immatics (Inst); Kite, a Gilead company (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Xcovery (Inst)
 
Ben C. Creelan
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene
Speakers' Bureau - ARIAD; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Takeda
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Penelope Ann Bradbury
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck
Expert Testimony - Merck
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Loxo; Takeda; Theravance
Research Funding - Adaptimmune (Inst); ARIAD; AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Affymetrix
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim; Genentech/Abbvie
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; GlaxoSmithKline; Inivata; Merck Serono; Novartis; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Melissa Lynne Johnson
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Genentech/Roche (Inst); Otsuka (I)
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); Genmab (Inst); Guardant Health (Inst); Hengrui Pharmaceutical (Inst); Janssen (Inst); Kadmon (Inst); Lilly (Inst); Loxo (Inst); Lycera (Inst); Merck (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Stem CentRx (Inst); Tarveda Therapeutics (Inst)
 
Raja Mudad
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Ryan J. Sullivan
Honoraria - Roche/Genentech
Consulting or Advisory Role - ACI Clinical; Amgen; Array BioPharma; Biodesix; BiolineRx; Merck; Novartis; Takeda; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - Boehringer Ingelheim
 
Francine Brophy
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune
 
Natalie Hyland
Employment - Adaptimmune
 
Karen Chagin
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - Adaptimmune
 
Tom Holdich
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune; AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - Adiga Life Sciences
 
Elliot Norry
Employment - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune; GlaxoSmithKline
 
Rafael G. Amado
Employment - Adaptimmune
Leadership - Adaptimmune
Stock and Other Ownership Interests - Adaptimmune; Amgen; GlaxoSmithKline